Pharmacy Business Loans: Buying a Pharmacy or a Partner's Share
Buying a pharmacy or a partner's share? How lenders fund goodwill and stock, read dispensing income and take security under pharmacy ownership law.
Whitecoat Hub
Pharmacy Business Loan · Goodwill and Stock · Ownership Rules
A pharmacy loan is not just a business loan with a dispensary attached. State law decides who can own the pharmacy and what a lender's security documents may say, and that shapes every layer of the finance.
Quick Answer
A pharmacy business loan funds the purchase of an existing community pharmacy or a partner's share, and it is built in layers: ownership approval first, then goodwill, then stock, then working capital, all under security documents your state's pharmacy law allows. Most purchases run on a business loan for the goodwill, with stock inside that loan or on a separate facility. The order matters, because in Victoria every loan and security agreement is examined by the Authority, and that review has to fit inside the settlement timeline.
Also called: pharmacy acquisition finance, pharmacy purchase loan, pharmacy goodwill loan. They describe the same need, except that a pharmacy goodwill loan covers only the goodwill layer, not the stock or the working capital.
What is a pharmacy business loan?
Buying an existing community pharmacy, or a partner's share in one, is funded by a pharmacy business loan covering the goodwill, the stock on the shelves and enough working capital to trade through the handover. In structure it is a business loan, usually secured over the business and backed by guarantees. The difference is that the loan documents have to fit pharmacy ownership law, which a café or clinic loan never has to consider.
What you are buying is a going concern: a licensed dispensary, a script history, a retail floor, staff and a lease. Fit-out for a new or relocated pharmacy is a separate job with its own approvals, covered in pharmacy fit-out finance. The wider mechanics of buying any health practice, from guarantees to declines, sit in our practice finance guide for medical, dental and vet owners, and more finance for health practice owners sits on the Whitecoat Hub.
Who can own a pharmacy in Australia, and how many?
Only registered pharmacists, and companies or partnerships they control, can own a community pharmacy in Australia, with limited exceptions set out in each state's law. In New South Wales, Victoria and Queensland one owner can hold an interest in no more than five pharmacies, at the time of writing. Other states and territories run their own versions of these rules, so the test that applies is the one where the pharmacy trades.
The detail differs by state. Queensland's Pharmacy Business Ownership Act 2024 commenced in full on 1 November 2025, moving pharmacy business licensing to the Queensland Pharmacy Business Ownership Council. In New South Wales only registered pharmacists can hold a financial interest in a pharmacy business, with limited exceptions. In Victoria the Victorian Pharmacy Authority licenses pharmacy businesses and examines the commercial arrangements around them, including the finance.
For a buyer this is the first gate, not paperwork. A lender typically will not settle until the buyer's eligibility is clear and any licence or approval is in hand, and a company buyer has to show who holds the shares and who controls the board.
Does buying a partner's share change the ownership test?
Buying a partner's share does not change the ownership test. The incoming partner must be eligible in their own right, and the pharmacies they already hold an interest in still count toward the state limit once the new share is added.
Can a lender take security over a pharmacy without breaching ownership rules?
A lender can take security over a pharmacy without breaching ownership rules, as long as the documents give it security without control. In Victoria, a lender's security interest sits outside the ownership limits only if the loan and security documents comply with the Pharmacy Regulation Act 2010, which makes void any term that gives a person who is not a licensee control of the business, payments linked to its profits, or access to its records beyond what compliance requires.
The Victorian Pharmacy Authority's commercial arrangement guidance also says every loan and security agreement is examined by the Authority. Build that review into the timeline, because a clause the Authority will not accept has to be redrafted before settlement. Queensland takes the same line: under its 2024 Act, terms that give a third party control of a pharmacy business are void, and penalties apply to the parties.
Lender can
- Take a registered security interest over the business assets and goodwill
- Ask for a director's guarantee and, where offered, property security
- Charge interest and fees that are not tied to the pharmacy's profits
- Receive the reporting it needs to check the loan is being met
Lender cannot
- Direct or control how the pharmacy is run
- Take a share of profits or payments linked to turnover
- Demand access to records beyond what compliance requires
- Rely on a clause that state law makes void
Whether a particular clause complies is a legal question. Have your solicitor read the lender's documents against your state's pharmacy law before you sign, not after the lender has issued them for execution.
How are pharmacies valued for sale?
Pharmacies are valued on maintainable earnings, adjusted for the things that make those earnings more or less likely to continue under a new owner. The headline drivers are script volume and mix, the share of income that comes from the retail floor, the lease and the location.
- Script volume and mix. A steady base of repeat scripts for ongoing conditions reads better than a volume built on one prescriber nearby. Specialist services such as a compounding pharmacy service add value only if they do not depend on the seller personally.
- Front-of-shop share. Retail sales carry their own margin and their own competition, so a pharmacy that leans heavily on them is read differently from one built on dispensing.
- The lease. Remaining term and options matter more than usual, because relocating a PBS-approved pharmacy needs approval and cannot be done at will.
- Location. Nearby medical centres, foot traffic and competing pharmacies all feed into whether the script base holds.
- The owner's hours. If the seller works most dispensing shifts, the buyer has to replace those hours with paid pharmacist wages, and the earnings are adjusted for that.
A lender does not simply adopt the agreed price. It reads the earnings that support the goodwill and may order its own valuation, which varies by lender. For how lenders approach goodwill across industries, see who funds goodwill when you buy a business.
How do lenders read pharmacy income?
Lenders read pharmacy income line by line, with dispensing and front-of-shop read separately because they behave differently. Dispensing income follows government remuneration and script volume; retail follows foot traffic and margin. A lender works through typically two years of financial statements, recent BAS and the dispensary's script reports, then tests each line below.
| Line | What it tells a lender | What can weaken it (indicative) |
|---|---|---|
| Dispensing income | The core, recurring revenue, set by script volume and PBS remuneration under the Community Pharmacy Agreement | Falling script numbers, a reliance on one nearby prescriber, remuneration changes not yet in the figures |
| Front-of-shop sales | How much of the business depends on retail rather than scripts | Heavy discounting, a large competitor nearby, fewer patient visits |
| Gross margin | Whether the pharmacy buys and prices well across both lines | A margin that moves sharply year to year without an explanation |
| Stock on hand and stock turn | How much cash sits on the shelves and how fast it sells | Slow-moving or expired stock, a stock figure that does not match the count |
| Wages | Whether the earnings survive paying for every pharmacist shift | Owner hours not costed at a market wage, roster gaps filled by the seller |
| Banner group fees | The cost of the buying group, marketing and systems the pharmacy belongs to | Fees that rise on a change of owner, or exit costs if the buyer wants to leave the group |
| Rent and lease term | Whether the site is secure for the life of the loan | A short remaining term, no options, a lease that cannot be assigned to the buyer |
The table is indicative. Each lender weights these lines differently, and some will look past a weak line if the dispensing base is strong and the buyer brings other security.
How do the 8CPA and 60-day dispensing affect a pharmacy loan?
The 8CPA and 60-day dispensing affect a pharmacy loan through the dispensing line: they shape what the government pays per script and how often patients come through the door, and a lender reads both in the most recent trading figures. Neither is a reason a pharmacy cannot be financed; both are reasons a lender looks closely at recent years.
The Eighth Community Pharmacy Agreement (8CPA) took effect on 1 July 2024 and runs to 30 June 2029. The Department of Health, Disability and Ageing puts its total envelope at around $26.5 billion, including around $13.54 billion in dispensing remuneration, at the time of writing. An addendum agreed on 12 June 2026 adjusts the wholesale mark-up from 1 July 2026, with an offsetting change to remuneration. For a buyer, the agreement sets the remuneration framework for most of an early loan term.
Sixty-day dispensing has applied since 1 September 2023, phased in over 12 months in three stages, letting patients on eligible ongoing medicines collect two months' supply on one script. Fewer visits can mean fewer chances to sell retail items alongside the script. Lenders therefore compare trading after the full phase-in with the years before it, and a pharmacy whose earnings held through the change is easier to fund.
Sources: Australian Government Department of Health, Disability and Ageing, Eighth Community Pharmacy Agreement topic page and the addendum agreed 12 June 2026. Read 13 October 2026.
How do you fund goodwill, stock and a partner buy-in?
You fund a pharmacy purchase in layers, in a set order, because each layer depends on the one before it. Where this commonly lands is a business loan for goodwill, stock inside that loan or on a revolving facility, and a working capital buffer, all secured under documents that pass the ownership rules.
- Ownership eligibility and approvals. Confirm you can own the pharmacy and that any licence, registration or regulator review of the finance documents is under way.
- Goodwill. Funded on a term business loan secured over the business, typically with guarantees and sometimes property. How much of the goodwill a lender will fund varies by lender and rests on the earnings it reads.
- Stock. Stock counted at settlement is paid for on top of goodwill. It can sit inside the main loan or on a business line of credit that flexes as stock levels move.
- Working capital. A buffer for wages, wholesaler terms and the first months under a new owner, so the purchase does not leave the business short of cash.
- Settlement. Lease assignment, the stock count and the regulator's clearance all have to line up on the same day.
Which lender types write pharmacy files, and on what terms, is compared in medical finance companies in Australia.
How is a partner buy-in structured?
A partner buy-in is structured as a purchase of shares in the pharmacy company, units in a trust or an interest in a partnership, depending on how the pharmacy is held. The lender funds the incoming partner or their entity, secured over the interest being bought and usually over other assets, and the existing owners may need to agree to that security. The same rule applies: the documents give the lender security, not a say in running the pharmacy. More on the mechanics sits in our practice buy-in glossary entry, and the wider purchase steps, including vendor finance, in our medical practice acquisition loan insight.
If you are also borrowing for a home soon after buying in, a recent change in how you are paid affects that application too; see One Doc home loans for pharmacists.
What stalls pharmacy purchase finance?
Pharmacy purchase finance mostly stalls on timing: ownership approval, regulator review of the loan documents and the lease all run on their own clocks, and settlement cannot happen until every one has cleared. On health practice purchases we've placed, the credit decision is rarely the last thing outstanding.
- Ownership approval and licensing. A licence or approval still pending at the settlement date holds up the funds.
- Regulator review of the loan documents. In Victoria the documents are examined by the Authority, and a clause it rejects means redrafting.
- Lease assignment. A landlord who is slow to consent, or wants new terms, delays everything behind it.
- The stock count. A count that comes in well above the estimate leaves a gap the loan was not sized for.
- Relocation plans. Relocating a PBS-approved pharmacy needs approval under the Pharmacy Location Rules; if a move is part of the plan, read pharmacy fit-out finance first.
Have ready the vendor's last two years of financial statements and BAS, script and stock reports, the lease and the banner group agreement, your own registration and financial position, and the entity details for the buyer. The Whitecoat pack sets out the full document list, and checking eligibility early shows which lenders will look at the file.
A pharmacy business loan is a business loan with ownership law built into it. Eligibility comes first, then goodwill funded on the earnings a lender reads, then stock counted at settlement and a working capital buffer. Dispensing and front-of-shop read separately, the 8CPA sets the remuneration framework to 30 June 2029, and in Victoria the finance documents are examined by the Authority. Security without control is the line every lender's documents have to hold.
Key takeaway: line up ownership approval, the lender's documents and your solicitor's review before you sign the sale contract, not after.Frequently Asked Questions
You get a business loan to buy a pharmacy by showing a lender that you are eligible to own it under your state's law, that its earnings support the goodwill price, and that the security documents comply with pharmacy ownership rules. Expect to provide the pharmacy's financial statements, script and stock reports, the lease and your own financial position. A broker can match the file to a lender with a pharmacy policy; start with a business loan conversation.
You can get a secured loan to buy a pharmacy, and most pharmacy purchase finance is secured over the business assets, often with a director's guarantee and sometimes property as well. The documents must not give the lender control of the pharmacy or a share of its profits, which state ownership law makes void. See how security works on a business loan.
One pharmacist can own an interest in no more than five pharmacies in New South Wales, Victoria and Queensland, at the time of writing. Other states and territories set their own rules, so check the law where the pharmacy trades. The ownership test is the first gate in any purchase; our practice finance guide covers the steps that follow.
Sixty-day dispensing does not automatically reduce what a pharmacy is worth, but it changes the script and foot traffic patterns a valuation rests on. Because it was phased in from 1 September 2023, buyers and lenders read trading after the phase-in rather than older years. A pharmacy whose earnings held through the change supports its goodwill more easily.
Someone who is not a pharmacist can lend money to a pharmacy owner, as long as the loan gives them no control of the business and no payments linked to its profits. That applies to lenders, family members and sellers offering vendor finance alike. In Victoria the loan and security documents are examined by the Authority, so have a solicitor check them first.
FBAA Accredited
